Status:
NOT_YET_RECRUITING
A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Progression
Postoperative Recovery
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
A single-center study on the effect of systemic/selective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation/tumor ratio between 0.5...
Detailed Description
A single-center study on the effect of systemic/selective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation/tumor ratio between 0.5...
Eligibility Criteria
Inclusion
- Patients enrolled in the study must meet all of the following conditions:
- Aged between 25 and 75 years;
- 2\. GGO is diagnosed by thin-section lung CT (thickness \<1.5mm) within one month before surgery;
- 3\. The maximum diameter of the GGO is smaller than 3cm;
- 4\. The solid component in GGO between 50%-100%;
- 5\. Preoperative examination showed that the patient could tolerate lobectomy;
- 6\. The patient is able to understand and comply with the study and has provided written informed consent.
Exclusion
- Patients meeting any of the following criteria are not eligible for this trial:
- 1\. Patients with a history of lung surgery;
- 2\. Postoperative pathology showed non-primary lung cancer;
- 3\. The scope of surgical resection is larger than one lung lobe;
- 4\. Patients with a history of other tumors;
- 5\. Patients with severe complications (coronary heart disease, valvular heart disease, end-stage renal disease, severe liver cirrhosis);
- 6\. Unable to cooperate with the researchers because of dementia or cognitive decline
- 7\. Other situations that are not in conformity with the standards and requirements of this trial.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05184829
Start Date
January 1 2022
End Date
December 31 2029
Last Update
January 11 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.